Seizure

SEATTLE — Subtypes of seizures have improved through the use of cenobamate, William E. Rosenfeld, MD, FAAN, said at the 2022 American Academy of Neurology annual meeting.

Treatment of rhythmic and periodic EEG patterns with anti-seizure medications in comatose survivors of cardiac arrest.

Intensive anti-seizure treatment suppressing rhythmic and periodic electroencephalographic patterns in comatose survivors of cardiac arrest did not result in fewer poor outcomes at 3 months vs. standard treatment, researchers reported.

The COVID-19 pandemic has significantly altered delivery of developmental services among children with acute provoked neonatal seizures, according to results of a prospective cohort study published in Pediatric Neurology.

Study results published in JAMA Neurology show higher odds of seizures during rewarming correlate with death or disability at 2 years in infants at risk, demonstrating the need for EEG monitoring during rewarming.

Long-term adjunctive perampanel treatment was efficacious and generally well tolerated among older patients with focal-onset seizures, according to findings presented at the annual meeting of the American Neurological Association.

Higher tissue 2-hydroxyglutarate concentration appeared to increase risk for preoperative seizures in isocitrate dehydrogenase 1/2 mutant tumors, according to study results published in Neurology.

Patients who received enzyme-inducing antiseizure medications had increased risk for incident cardiovascular disease, according to results of a cohort study published in JAMA Neurology.

Levetiracetam was well tolerated and appeared to improve performance on spatial memory and executive function tasks among patients with Alzheimer’s disease, according to results of a randomized clinical trial in JAMA Neurology.

Cannabidiol transdermal gel improved outcomes among children with developmental and epileptic encephalopathies, according to results of a nonrandomized controlled trial published in JAMA Network Open.